Walleye Trading LLC Bei Gene, Ltd. Put Options Transaction History

Walleye Trading LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 21, 2023	BUY	$179.87 - $225.13 $71,948 - $90,052	400 New	400 $71,000
Q2 2023 Aug 14, 2023	SELL	$178.3 - $266.78 $338,770 - $506,881	-1,900 Reduced 36.54%	3,300 $588,000
Q1 2023 May 15, 2023	BUY	$215.53 - $274.5 $840,567 - $1.07 Million	3,900 Added 300.0%	5,200 $1.12 Million
Q4 2022 Feb 14, 2023	BUY	$125.51 - $229.3 $163,163 - $298,090	1,300 New	1,300 $285,000
Q1 2020 May 15, 2020	SELL	$121.84 - $173.19 $158,392 - $225,147	-1,300 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$115.78 - $208.34 $185,248 - $333,344	-1,600 Reduced 55.17%	1,300 $215,000
Q3 2019 Nov 14, 2019	BUY	$120.61 - $148.29 $48,244 - $59,316	400 Added 16.0%	2,900 $355,000
Q1 2019 May 15, 2019	BUY	$122.82 - $151.83 $49,128 - $60,732	400 Added 19.05%	2,500 $330,000
Q3 2018 Nov 14, 2018	BUY	$152.62 - $189.66 $320,502 - $398,286	2,100 New	2,100 $362,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.2B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.